WHITNEY NELSON: Open Payments
NPI 1508465121 · SALYERSVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$830 in 46 payments from 8 companies in 2025. Trend: 2023 $326 · 2024 $191 · 2025 $830
Food & beverage: $830
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 20 | $393 |
| ABBVIE INC. | 15 | $255 |
| Amgen Inc. | 4 | $60 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $40 |
| GlaxoSmithKline, LLC. | 2 | $39 |
| AstraZeneca Pharmaceuticals LP | 1 | $22 |
| PFIZER INC. | 1 | $15 |
| Axsome Therapeutics, Inc. | 1 | $6 |
Products named: CAPLYTA, QULIPTA, JOURNAVX, UBRELVY, TRELEGY ELLIPTA, REPATHA, OTEZLA, AIRSUPRA.
Industry payments across KY — which companies pay providers there.
